ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 104 filers reported holding ADICET BIO INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $335,476 | +338.9% | 244,873 | +678.5% | 0.00% | – |
| Q2 2023 | $76,433 | -70.3% | 31,454 | -29.5% | 0.00% | – |
| Q1 2023 | $256,925 | -83.9% | 44,605 | -60.3% | 0.00% | -100.0% |
| Q3 2022 | $1,598,000 | -67.0% | 112,355 | -66.1% | 0.00% | -66.7% |
| Q2 2022 | $4,844,000 | +9.7% | 331,812 | +50.1% | 0.01% | +50.0% |
| Q1 2022 | $4,416,000 | +18.8% | 221,127 | +4.1% | 0.00% | +33.3% |
| Q4 2021 | $3,716,000 | +980.2% | 212,457 | +384.3% | 0.00% | – |
| Q3 2021 | $344,000 | -53.6% | 43,871 | -39.1% | 0.00% | -100.0% |
| Q2 2021 | $741,000 | +74.4% | 72,034 | +121.7% | 0.00% | – |
| Q1 2021 | $425,000 | +23.5% | 32,486 | +32.5% | 0.00% | – |
| Q4 2020 | $344,000 | +135.6% | 24,517 | +99.4% | 0.00% | – |
| Q3 2020 | $146,000 | – | 12,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |